Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective.

نویسندگان

  • Neil Lineberry
  • Jesse A Berlin
  • Bernadette Mansi
  • Susan Glasser
  • Michael Berkwits
  • Christian Klem
  • Ananya Bhattacharya
  • Leslie Citrome
  • Robert Enck
  • John Fletcher
  • Daniel Haller
  • Tai-Tsang Chen
  • Christine Laine
چکیده

and introduction [Abstract] 4. Avoid use of overly general text descriptions for adverse events, including in abstracts. Abstracts should include a phrase or sentence summarizing the most clinically relevant adverse event data with frequency percentages consistent with those presented in the main text of the publication. [Abstract and introduction] “(1, 2) If the study collected data on harms and benefits, the title or abstract, and introduction, should so state.”

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Reporting of harms outcomes: a comparison of journal publications with unpublished clinical study reports of orlistat trials.

BACKGROUND The quality of harms reporting in journal publications is often poor, which can impede the risk-benefit interpretation of a clinical trial. Clinical study reports can provide more reliable, complete, and informative data on harms compared to the corresponding journal publication. This case study compares the quality and quantity of harms data reported in journal publications and clin...

متن کامل

Increasing the Number of Adverse Drug Reactions Reporting: the Role of Clinical Pharmacy Residents

Detection of adverse drug reactions (ADRs) in hospitals provides an important measure of the burden of drug related morbidity on the healthcare system. Spontaneous reporting of ADRs is scare and several obstacles to such reporting have been identified formerly. This study aimed to determine the role of clinical pharmacy residents in ADR reporting within a hospital setting.Clinical pharmacy resi...

متن کامل

Increasing the Number of Adverse Drug Reactions Reporting: the Role of Clinical Pharmacy Residents

Detection of adverse drug reactions (ADRs) in hospitals provides an important measure of the burden of drug related morbidity on the healthcare system. Spontaneous reporting of ADRs is scare and several obstacles to such reporting have been identified formerly. This study aimed to determine the role of clinical pharmacy residents in ADR reporting within a hospital setting.Clinical pharmacy resi...

متن کامل

Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion

OBJECTIVE To investigate whether published results of industry funded trials of recombinant human bone morphogenetic protein 2 (rhBMP-2) in spinal fusion match underlying trial data by comparing three different data sources: individual participant data, internal industry reports, and publicly available journal publications and conference abstracts. DATA COLLECTION AND SYNTHESIS The manufactur...

متن کامل

Adverse event reporting in randomised controlled trials of neuropathic pain: considerations for future practice.

High-quality information on the potential benefit and harm of a drug is required for patients and clinicians to make informed treatment decisions and to enable cost-effectiveness modeling to be undertaken. This systematic review describes the collection and reporting of adverse event data as presented in published clinical trials of neuropathic pain for the evaluation of antidepressant or antie...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • BMJ

دوره 355  شماره 

صفحات  -

تاریخ انتشار 2016